Skip to main content
logo
BioNTech SE (BVMF:B1NT34)
Brazil flag Brazil · Delayed Price · Currency is BRL
32.19
+0.09 (0.28%)
At close: Dec 3, 2025

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
COVID-19 Vaccine Revenue (Post-FY2023 Reporting)
2.43B
Log In
Log In
Log In
Log In
Upgrade
COVID-19 Vaccine Revenue (Post-FY2023 Reporting) Growth
-18.63%
Log In
Log In
Log In
Log In
Upgrade
Other Sales Revenue (Post-FY2023 Reporting)
319.00M
Log In
Log In
Log In
Log In
Upgrade
Other Sales Revenue (Post-FY2023 Reporting) Growth
6.60%
Log In
Log In
Log In
Log In
Upgrade
Research & Development
-
Log In
Log In
Log In
Log In
Upgrade
Research & Development Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other Sales Revenue (Pre-FY2024 Reporting)
-
Log In
Log In
Log In
Log In
Upgrade
Other Sales Revenue (Pre-FY2024 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
COVID-19 Vaccine Revenue (Pre-FY2024 Reporting)
-
Log In
Log In
Log In
Log In
Upgrade
COVID-19 Vaccine Revenue (Pre-FY2024 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade